Boehringer Ingelheim has actually likewise introduced 2 stage III tests for survodutide to additionally explore the medication’s performance.
发布者:BY MIKKEL AABENHUS HEMMINGSEN,转转请注明出处:https://robotalks.cn/fda-grants-breakthrough-therapy-designation-to-boehringer-ingelheims-survodutide/